ASAP Fertility IV - $300 Developed after research and consultation with reproductive endocrinologists, the ASAP Fertility IV is designed to deliver high concentrations of anti-oxidants via 100% intravenous absorption
Chronic inflammation prompts specialized liver cells to produce scar tissue, leading to fibrosis of the liver
Stimulant laxatives including bisacodyl (Dulcolax) or senna are appropriate for short-term or rescue therapy
BPC-157 is not approved by any drug regulatory agency for human use, and there is limited data regarding its effectiveness on humans
individuals with obesity are 35 times more likely to develop OA [75], and most OA patients undergoing total joint replacement surgery for end-stage OA have obesity or are overweight [76]
Furthermore, KFF reports that the number of prescriptions increased by more than 400% between 2019 and 2023, and in 2023, spending per prescription before rebates reached more than $900